Su Xie

3PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 27, 2026
Suppressing M2 Macrophage Polarization by Glycine Combined with β-Elemene via the IL-6/JAK2/STAT3 Signaling Pathway to Inhibit Triple-Negative Breast Cancer Progression.

|Mar 11, 2026
Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway.

Jingzhe Zhao, Xiaoshan Luo, Huan Li

|Dec 17, 2025
The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the Number of Myeloid-Derived Suppressor Cells (MDSCs) via the JAK2/STAT3 Pathway.

Yazhen Huang, YanYun Meng, XiaoShan Lou

Pageof 1

Frequent Collaborators

1 joint publications

Doudou Feng

1 joint publications

Jingzhe Zhao